Delivery Order SPE2DB22D2103-SPE2DB25FR9QH
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for the supply of Concerta ER 36 mg tablets (100 count units) with a ceiling value of $4,310.92. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 5, 2025. The award fulfills the federal government's pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,289.80 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of Concerta ER 36 mg tablets (100 count) valued at $17,812.02. This competitively awarded, firm fixed-price delivery order has a completion date of September 11, 2025, and represents a child contract under the Defense Logistics Agency's broader pharmaceutical supply framework. The contract type and compressed timeline indicate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,459.67 on July 22, 2025, for the supply of Concerta ER Tabs 36mg. This firm fixed price contract, which is scheduled for completion by July 23, 2025, represents a competitive award with no set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. The place of performance is located at the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,786.94 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) on May 27, 2025, with completion scheduled for May 28, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,992.71 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on July 28, 2025, with completion targeted for July 29, 2025. This competitively awarded, non-set-aside contract utilized firm fixed pricing and identifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order represents a child...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Concerta ER Tablets 36mg, with a ceiling value of $22,714.79. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $5,573.88. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order is issued as a child contract under AmerisourceBergen's...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9QHDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 6, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This firm fixed-price delivery order, valued at $15,886.60, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award involved no set-aside designation and was competitively awarded through open competition. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, supporting military and federal healthcare systems. The company's comprehensive pharmaceutical portfolio under its DLA Troop Support Medical IDC encompasses a broad range of therapeutic products including specialty medications, brand-name and generic drugs, and medical supplies. The SPE2DX contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply military healthcare programs worldwide, positioning the company as a key provider within the Defense Logistics Agency's medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 8/6/25 |